Westlake Village BioPartners Announces $450 Million Venture Capital Funding Pool
Westlake’s third fund of $450 million will be used to grow early stage biotechnology companies.
Westlake Village BioPartners, a Los Angeles area-based venture capital firm, announced the launch of its oversubscribed third fund of $450 million to incubate and grow early stage next-generation biotechnology companies on July 17, 2023. The new fund will be managed by Beth Seidenberg, founding managing director; Mira Chaurushiya, managing director; and David Allison, recently appointed managing director.
According to a company press release, the new fund brings the total raised since the company’s launch in 2018 to approximately $1.3 billion. The full list of companies in Westlake’s current investment portfolio can be found here.
“This new fund will enable us to continue to do what we do best – build great companies from the ground up that make a difference for patients and generate outsized returns for investors regardless of market conditions,” said Seidenberg in the release. “Our investors recognize our strategy is working and have demonstrated their commitment through this new investment.”
Source: Westlake
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
April 23rd 2025The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.
